These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 29542214)
1. Circulating tumor DNA as a biomarker and liquid biopsy in head and neck squamous cell carcinoma. Payne K; Spruce R; Beggs A; Sharma N; Kong A; Martin T; Parmar S; Praveen P; Nankivell P; Mehanna H Head Neck; 2018 Jul; 40(7):1598-1604. PubMed ID: 29542214 [TBL] [Abstract][Full Text] [Related]
2. Liquid biopsy: An emerging prognostic and predictive tool in Head and Neck Squamous Cell Carcinoma (HNSCC). Focus on Circulating Tumor Cells (CTCs). Economopoulou P; Kotsantis I; Kyrodimos E; Lianidou ES; Psyrri A Oral Oncol; 2017 Nov; 74():83-89. PubMed ID: 29103757 [TBL] [Abstract][Full Text] [Related]
3. Droplet digital PCR for detection and quantification of circulating tumor DNA in plasma of head and neck cancer patients. van Ginkel JH; Huibers MMH; van Es RJJ; de Bree R; Willems SM BMC Cancer; 2017 Jun; 17(1):428. PubMed ID: 28629339 [TBL] [Abstract][Full Text] [Related]
4. Circulating tumor-derived DNA may permit the early diagnosis of head and neck squamous cell carcinomas. Nunes DN; Kowalski LP; Simpson AJ Int J Cancer; 2001 Apr; 92(2):214-9. PubMed ID: 11291048 [TBL] [Abstract][Full Text] [Related]
5. A liquid biopsy for head and neck cancers. Schmidt H; Kulasinghe A; Perry C; Nelson C; Punyadeera C Expert Rev Mol Diagn; 2016; 16(2):165-72. PubMed ID: 26631411 [TBL] [Abstract][Full Text] [Related]
6. A comparison between mutational profiles in tumour tissue DNA and circulating tumour DNA in head and neck squamous cell carcinoma - A systematic review. Huang X; Leo P; Jones L; Duijf PHG; Hartel G; Kenny L; Vasani S; Punyadeera C Mutat Res Rev Mutat Res; 2024; 793():108477. PubMed ID: 37977279 [TBL] [Abstract][Full Text] [Related]
7. Tumour-derived plasma cell-free DNA in patients with head and neck cancer: A short review. Rave-Fränk M Cancer Radiother; 2017 Oct; 21(6-7):554-556. PubMed ID: 28847459 [TBL] [Abstract][Full Text] [Related]
8. Circulating tumor cells as biomarkers of head and neck squamous cell carcinoma: an updated view. Mangano A; Mangano A; Lianos GD; Levrini L; Picone M; Boni L; Dionigi G Future Oncol; 2015; 11(13):1851-3. PubMed ID: 26161921 [No Abstract] [Full Text] [Related]
9. Individualized circulating tumor DNA monitoring in head and neck squamous cell carcinoma. Kogo R; Manako T; Iwaya T; Nishizuka S; Hiraki H; Sasaki Y; Idogawa M; Tokino T; Koide A; Komune N; Yasumatsu R; Nakagawa T Cancer Med; 2022 Nov; 11(21):3960-3968. PubMed ID: 35352507 [TBL] [Abstract][Full Text] [Related]
10. Circulating tumour DNA alterations: emerging biomarker in head and neck squamous cell carcinoma. Huang X; Duijf PHG; Sriram S; Perera G; Vasani S; Kenny L; Leo P; Punyadeera C J Biomed Sci; 2023 Aug; 30(1):65. PubMed ID: 37559138 [TBL] [Abstract][Full Text] [Related]
11. Circulating tumour DNA alterations as biomarkers for head and neck cancer: a systematic review. Pall AH; Jakobsen KK; Grønhøj C; von Buchwald C Acta Oncol; 2020 Jul; 59(7):845-850. PubMed ID: 32223478 [No Abstract] [Full Text] [Related]
12. Liquid Biopsy: A Future Tool for Posttreatment Surveillance in Head and Neck Cancer? van Ginkel JH; Huibers MMH; Noorlag R; de Bree R; van Es RJJ; Willems SM Pathobiology; 2017; 84(3):115-120. PubMed ID: 27974721 [TBL] [Abstract][Full Text] [Related]
13. The development of a liquid biopsy for head and neck cancers. Schmidt H; Kulasinghe A; Kenny L; Punyadeera C Oral Oncol; 2016 Oct; 61():8-11. PubMed ID: 27688098 [TBL] [Abstract][Full Text] [Related]
14. Cell-free DNA and circulating tumor cell kinetics in a pre-clinical head and neck Cancer model undergoing radiation therapy. Muhanna N; Eu D; Chan HHL; Douglas C; Townson JL; Di Grappa MA; Mohamadi RM; Kelley SO; Bratman SV; Irish JC BMC Cancer; 2021 Oct; 21(1):1075. PubMed ID: 34600526 [TBL] [Abstract][Full Text] [Related]
15. Liquid BIOpsy for MiNimal RESidual DiSease Detection in Head and Neck Squamous Cell Carcinoma (LIONESS)-a personalised circulating tumour DNA analysis in head and neck squamous cell carcinoma. Flach S; Howarth K; Hackinger S; Pipinikas C; Ellis P; McLay K; Marsico G; Forshew T; Walz C; Reichel CA; Gires O; Canis M; Baumeister P Br J Cancer; 2022 May; 126(8):1186-1195. PubMed ID: 35132238 [TBL] [Abstract][Full Text] [Related]
16. Plasma circulating tumor DNA as a potential tool for disease monitoring in head and neck cancer. Egyud M; Sridhar P; Devaiah A; Yamada E; Saunders S; Ståhlberg A; Filges S; Krzyzanowski PM; Kalatskaya I; Jiao W; Stein LD; Jalisi S; Godfrey TE Head Neck; 2019 May; 41(5):1351-1358. PubMed ID: 30554450 [TBL] [Abstract][Full Text] [Related]
17. Serum biomarkers for detection of head and neck squamous cell carcinoma. Mydlarz WK; Hennessey PT; Wang H; Carvalho AL; Califano JA Head Neck; 2016 Jan; 38(1):9-14. PubMed ID: 24995714 [TBL] [Abstract][Full Text] [Related]
18. Targeted sequencing reveals TP53 as a potential diagnostic biomarker in the post-treatment surveillance of head and neck cancer. van Ginkel JH; de Leng WW; de Bree R; van Es RJ; Willems SM Oncotarget; 2016 Sep; 7(38):61575-61586. PubMed ID: 27528217 [TBL] [Abstract][Full Text] [Related]
19. Cell-free mitochondrial DNA copy number variation in head and neck squamous cell carcinoma: A study of non-invasive biomarker from Northeast India. Kumar M; Srivastava S; Singh SA; Das AK; Das GC; Dhar B; Ghosh SK; Mondal R Tumour Biol; 2017 Oct; 39(10):1010428317736643. PubMed ID: 29072129 [TBL] [Abstract][Full Text] [Related]
20. The role of tumor DNA as a diagnostic tool for head and neck squamous cell carcinoma. Chan JYK; Zhen G; Agrawal N Semin Cancer Biol; 2019 Apr; 55():1-7. PubMed ID: 30082187 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]